Here, we addressed two logical questions: (1) whether enhanced levels of TTP in non-HPCs would ameliorate endotoxin-induced ALI, (2) whether enhanced levels of TTP in HPCs would confer protection against endotoxin-induced ALI. This evidence concerns the gene ZFP36 and acute respiratory distress syndrome.